Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > MARCH 19>>>>LAWSUIT FILING DATE?
View:
Post by ISAloser247 on Mar 09, 2012 1:39pm

MARCH 19>>>>LAWSUIT FILING DATE?

...the Edmonton car-counter- who drives by and checks on the lights at ISA headquarters---asks If I was behind

 the GOLD SKELETON KEY DISPLAY OUTSIDE ISOTECHNIKA ON 50 STR, in Edmonton.   Considering all the

'skeletons' the investigator has dug up,  the  'coincidence"  is golden.   HE also mentioned a TV

report of advanced STEM CELL DEVELOPMENT , where people undergoing kidney transplants , have

STEM CELLS removed prior to surgery, then pumped in after,  RESULTING IN LESS  ANTI-REJECTION

TOXICITY,  WITH VERY PROMISING RESULTS!!!!!!! FOCUS ON ISA SCIENCE,    WHILE THE REST OF THE WORLD MOVES ON IN ADVANCEMENT!!!!!!

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities